4//SEC Filing
O'Dowd Hugh 4
Accession 0001694187-19-000012
CIK 0001694187other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 6:18 PM ET
Size
7.3 KB
Accession
0001694187-19-000012
Insider Transaction Report
Form 4
O'Dowd Hugh
DirectorPresident & CEO
Transactions
- Award
Common Stock
2019-02-27+100,000→ 545,868 total - Award
Stock Option (Right to Buy)
2019-02-27+200,000→ 200,000 totalExercise: $6.13Exp: 2029-02-26→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]Mr. O'Dowd was awarded 100,000 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. The Restricted Stock Units shall vest annually over three years, with one-third vesting on the last day of February 2020 and the balance vesting in two equal annual installments thereafter, subject to the Reporting Person's continued service. The Restricted Stock Units may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]This option shall vest and become exercisable in equal monthly installments over four years commencing on February 27, 2019.
Documents
Issuer
Neon Therapeutics, Inc.
CIK 0001694187
Entity typeother
Related Parties
1- filerCIK 0001741171
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 6:18 PM ET
- Size
- 7.3 KB